OSCC tissues; adjacent normal tissues; lymph node metastasis samples; xenograft tumor tissues; lung tissues
HOK; Cal-27; SCC-25; SCC-9; HSC-3
cell line-derived xenograft
Hippo/YAP (inhibits); EMT (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); metastasis (inhibits); ceRNA regulation (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; IF (Immunofluorescence); IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis
Low circ_0000140 levels correlate with higher lymph node metastasis, advanced TNM stage, and poor overall survival in OSCC patients.
circ_0000140 (from KIAA0907) is down-regulated in OSCC and functions as a tumor suppressor. It sponges miR-31 to increase LATS2, inhibit Hippo/YAP signaling output and EMT, thereby reducing proliferation, invasion/migration and lung metastasis, and higher circ_0000140 associates with better survival.
0.8814
circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
combined biological and clinical study